01 February 2004
The effect of eight weeks of rabeprazole therapy on esophageal pH and motility and nitric oxide plasma level in patients with erosive esophagitis
Maciej Świątkowski, Jacek Budzyński, Maria Kłopocka, Krzysztof Grad, Grzegorz Pulkowski, Beata Augustyńska, Karol Suppan, Jacek FabisiakMed Sci Monit 2004; 10(2): CR46-51 :: ID: 11593
Abstract
Background:Esophageal clearance, an important pathogenetic factor in gastroesophageal reflux disease, depends mainly on motility. Motility disturbances can be secondary to gastric output reflux. Nitric oxide influences esophageal motility. The aim of this study was to determine the effect of eight weeks of gastric acid secretion suppression with rabeprazole (20 mg/day) on esophageal motility.Material/Methods: 20 patients with erosive esophagitis were studied. At study start and two weeks after the end of therapy, we recorded the results of interview, endoscopy, gastric and esophageal mucosa biopsy, 24-h esophageal pH-metry and manometry, and NO metabolites plasma concentration, determined spectrophotometrically (OXIS).Results: All patients reported improvement and remained free of symptoms two weeks later. In 60% of cases, improvement of esophageal mucosa appearance was observed in endoscopic and histological examination. In follow-up we found a significantly smaller number of acid gastrooesophageal refluxes (p<0.05), reduced DeMeester score for pH range >7 (p<0.05), and greater % of time within the esophageal pH range 6–7 (p<0.05). Other esophageal pH-metry and 24-h manometry parameters did not change significantly. NO metabolites plasma concentration increased significantly (p=0.039).
Conclusions: Clinical improvement after eight weeks of therapy with rabeprazole was connected with endoscopic changes only in 60% of our patients. Rabeprazole therapy did not influence esophageal motility, despite increased plasma levels of NO metabolites. Patients with erosive esophagitis need maintenance therapy, since as soon as two weeks after the end of treatment the % of monitoring time with esophageal pH<4 was similar to study start.
Keywords: 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Ulcer Agents - therapeutic use, Benzimidazoles - therapeutic use, Esophagitis, Peptic - blood, Esophagitis, Peptic - drug therapy, Esophagitis, Peptic - metabolism, Esophagitis, Peptic - physiopathology, Esophagus - metabolism, Esophagus - physiopathology, Gastrointestinal Motility - drug effects, Hydrogen-Ion Concentration, Manometry, Monitoring, Ambulatory, Nitric Oxide - blood, Nitrites - blood, Omeprazole - analogs & derivatives, Time Factors, 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Ulcer Agents - therapeutic use, Benzimidazoles - therapeutic use, Esophagitis, Peptic - physiopathology, Esophagus - physiopathology, Gastrointestinal Motility - drug effects, Hydrogen-Ion Concentration, Manometry, Monitoring, Ambulatory, Nitric Oxide - blood, Nitrites - blood, Omeprazole - analogs & derivatives, rabeprazole, Time Factors
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952